Posterolateral lumbar fusions in athymic rats: characterization of a model

Steinmann, 1992, Pseudarthosis of the spine, Clin Orthop, 284, 80, 10.1097/00003086-199211000-00011 Gupta, 2001, Perioperative and long-term complications of iliac crest bone graft harvesting for spinal surgery: a quantitative review of the literature, Int Med J, 8, 163 Boden, 1998, Lumbar spine fusion by local gene therapy with cDNA encoding a novel osteoinductive protein (LMP-1), Spine, 23, 2486, 10.1097/00007632-199812010-00003 Wang JC, Davies M, Kanim LEA, Ukatu CJ, Dawson EG, Lieberman JR. Prospective comparison of commercially available demineralized bone matrix for spine fusion. Paper presented at: North American Spine Society Meeting; October 25–28, 2000; New Orleans, LA. Boden, 1995, An experimental lumbar intertransverse process spinal fusion model: radiographic, histologic, and biomechanical healing characteristics, Spine, 20, 412, 10.1097/00007632-199502001-00003 Grauer, 2001, Evaluation of OP-1 as a graft substitute for intertransverse process lumbar fusion, Spine, 26, 127, 10.1097/00007632-200101150-00004 Cunningham, 2002, Osseointegration of autograft versus osteogenic protein-1 in posterolateral spinal arthrodesis: emphasis on the comparative mechanisms of bone induction, Spine J, 2, 11, 10.1016/S1529-9430(01)00170-X David, 1999, Lumbar spinal fusion using recombinant human bone morphogenetic protein in the canine: a comparison of three dosages and two carriers, Spine, 24, 1973, 10.1097/00007632-199910010-00002 Aspenberg, 1988, Rabbit bone matrix induces bone formation in the athymic rat, Acta Orthop Scand, 59, 276, 10.3109/17453678809149362 Edwards, 1998, Osteoinduction of human demineralized bone: characterization in a rat model, Clon Orthop Rel Res, 357, 219, 10.1097/00003086-199812000-00028 Alden, 1999, In vivo enchondral bone formation using a bone morphogenetic protein 2 adenoviral vector, Human Gene Ther, 10, 2245, 10.1089/10430349950017220 Varady, 2001, Morphologic analysis of BMP-9 gene therapy-induced osteogenesis, Human Gene Ther, 12, 697, 10.1089/104303401300057423 Lee YP, Wang JC, Kamin LEA, Jo MJ, Lieberman JR. The direct comparison of different commercially available demineralized bone matrix substances in an athymic rat model. Paper presented at: North American Spine Society Meeting; October 31–November 3, 2001; Seattle, WA. Alden, 1999, Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy, J Neurosurg (Spine 1), 90, 109, 10.3171/spi.1999.90.1.0109 Helm, 2000, Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent, J Neurosurg (Spine 2), 92, 191, 10.3171/spi.2000.92.2.0191 Glassman, 1998, The effect of postoperative nonsteroidal anti-inflammatory drug administrations on spinal fusion, Spine, 23, 834, 10.1097/00007632-199804010-00020 Martin, 1999, Recombinant human bone morphogenetic protein-2 overcomes the inhibitory effect of ketorolac, a nonsteroidal anti-inflammatory drug (NSAID), on posterolateral lumber intertransverse process spine fusion, Spine, 24, 2188, 10.1097/00007632-199911010-00003 Buchinsky, 1995, Bone mineral metabolism in T lymphocyte-deficient and replete strains of rat, J Bone Mineral Res, 10, 1556, 10.1002/jbmr.5650101018 Kirkeby, 1991, Bone metabolism and repair are normal in athymic rats, Act Orthop Scand, 62, 253, 10.3109/17453679108993603 Baron, 1983, Processing of undecalcified bone specimens for histomorphometry, 13 Aspenberg, 1991, Monkey bone matrix induces bone formation in the athymic rat, but not in adult monkeys, J Ortho Research, 9, 20, 10.1002/jor.1100090104